---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-23-000003"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:23:31.091010+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Integra pre-announces Q4 rev ~$397-398M, adj EPS above guidance; FY rev ~$1,557-1,558M

## Summary
- Q4 2022 revenue expected $397M-$398M, down ~2% reported, up ~3% organic vs Q4 2021.
- Adjusted EPS expected above high end of October guidance range.
- FY2022 revenue expected $1,557M-$1,558M, up ~1% reported, +4% organic.
- Full-year adjusted EPS above high end of October guidance and above midpoint of original Feb guidance.
- Company presenting at JP Morgan Healthcare Conference on Jan 11, 2023.

## SEC filing metadata
- accession: 0000917520-23-000003
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752023000003/0000917520-23-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752023000003/iart-20230110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-23-000003
- JSON: https://secwatch.observer/filing/0000917520-23-000003.json
- Plain text: https://secwatch.observer/filing/0000917520-23-000003.txt

## Key facts
- Earnings Releases
  INTEGRA LIFESCIENCES HOLDINGS CORP updated its fourth quarter and full-year 2022 guidance (reaffirmed).
  - Period: fourth quarter and full-year 2022
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: On January 10, 2023, Integra LifeSciences Holdings Corporation (the "Company") issued a press release announcing certain unaudited, preliminary fourth quarter and full-year 2022 financial results.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752023000003/0000917520-23-000003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.